Donate
Search
 Submission of a new form of natalizumab (Tysabri®) for RRMS to PBAC meeting March 2023

Medication Subsidy (PBAC), Medications and Treatments, Disease Modifying Therapy, DMT, Pharmaceutical Benefits Advisory Committee, PBAC

MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

Facebook-f X-twitter Linkedin-in Youtube Spotify Paper-plane

Quick links

© 2024 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2024 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT
Read More
NDIS Review Submission
2023-24 Pre-Budget Submission

Newsletter subscription

  • Enter your details

Submission of a new form of natalizumab (Tysabri®) for RRMS to PBAC meeting March 2023